AstraZeneca (CHIX:AZNL) Ending Cash Position : £5,248 Mil (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is AstraZeneca Ending Cash Position?

AstraZeneca's Ending Cash Position for the quarter that ended in Jun. 2024 was £5,248 Mil.

AstraZeneca's quarterly Ending Cash Position increased from Dec. 2023 (£4,453 Mil) to Mar. 2024 (£6,054 Mil) but then declined from Mar. 2024 (£6,054 Mil) to Jun. 2024 (£5,248 Mil).

AstraZeneca's annual Ending Cash Position increased from Dec. 2021 (£4,541 Mil) to Dec. 2022 (£4,912 Mil) but then declined from Dec. 2022 (£4,912 Mil) to Dec. 2023 (£4,453 Mil).

AstraZeneca Ending Cash Position Historical Data

The historical data trend for AstraZeneca's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Ending Cash Position Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

3,985.15

5,614.22

4,540.58

4,912.04

4,453.23

AstraZeneca Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial															4,333.03	3,732.15	4,453.23	6,053.60	5,248.12

AstraZeneca Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

AstraZeneca's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4726.57	+	-273.34
	=	4,453

AstraZeneca's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6045.912	+	-797.79
	=	5,248

AstraZeneca Ending Cash Position Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (CHIX:AZNl) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZN1:Mexico AZNN:Mexico AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZNA:Austria AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

AstraZeneca Headlines

No Headlines